Nick Leschly - 01 Feb 2023 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
President and CEO, Director
Signature
/s/ Teresa Jurgensen, Attorney-in-Fact
Issuer symbol
TSVT
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
03 Feb 2023, 15:59:18 UTC
Previous filing
17 Jan 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +81,250 +15% $0.000000 615,643 01 Feb 2023 Direct F1
transaction TSVT Common Stock Award $0 +428,571 +70% $0.000000 1,044,214 01 Feb 2023 Direct F2
holding TSVT Common Stock 15,233 01 Feb 2023 Nick Leschly 2001 Trust
holding TSVT Common Stock 41,000 01 Feb 2023 Nick Leschly Irrevocable GST Trust of 2019

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Option (Right to buy) Award $0 +162,500 $0.000000 162,500 01 Feb 2023 Common Stock 162,500 $13.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit award vests over a four-year period at the rate of 25% on 01/01/2024, 25% on 01/01/2025, 25% on 01/01/2026, and 25% on 01/01/2027.
F2 This restricted stock unit award vests over a three-year period at the rate of 40% on 01/01/2024, 40% on 01/01/2025, and 20% on 01/01/2026.
F3 This stock option vests over a four-year period at the rate of 25% on 01/01/2024, and then in 36 equal monthly installments thereafter.